syndrome (RDS), cerebral palsy and neonatal death upon steroid administration. All probabilities and utilities were derived from the literature. Neonatal outcomes included IUFD, RDS, cerebral palsy, and neonatal death. Maternal outcomes included maternal death and rates of severe hemorrhage defined as bleeding requiring greater than 10 units of blood products. RESULTS: In a theoretical cohort of 10,000 women with placenta accreta, scheduled cesarean hysterectomy at 35 weeks of gestation with corticosteroid administration optimized maternal and neonatal outcomes (table) . Delivery at 32 weeks resulted in the fewest maternal deaths (298) and incidents of severe hemorrhage (194). Neonatal outcomes except for IUFD were optimized with delivery at 37 weeks of gestation and included 23 cases of neonatal death, 55 cases of cerebral palsy, and 482 cases of RDS. CONCLUSION: Based on our analysis, optimal management for placenta accreta spectrum is a scheduled cesarean hysterectomy at 35 weeks gestation in a multidisciplinary care center with prior corticosteroid administration. Further efforts to identify those patients at risk of requiring an emergent delivery would help to further optimize maternal and neonatal outcomes. OBJECTIVE: To validate the accuracy of an external device which monitors uterine electrical activity by comparing it to tocodynamometry among obese patients. STUDY DESIGN: This was a prospective observational study of laboring women at Montefiore Medical Center from February 2017 to April 2018. Inclusion criteria: maternal age >18 years old, singleton pregnancy, gestational age > 24 weeks and BMI >/¼ 30 kg/m2. Exclusion criteria: allergy to silver, implanted electronic device of any kind and irritated skin or open wound on the abdominal wall. Patients were monitored simultaneously with the EUM device, EUM300 (OB Tools, Migdal HaEmek, Israel), and by TOCO for at least 30 minutes. Two blinded obstetricians reviewed the tracings. The primary outcome of the study was continuous, interpretable tracing and secondary outcomes were total number of contractions, timing of onset of contractions and duration of contractions. Based on McNemar's test to compare proportion of discontinuity between the two methods, enrolling 55 patients provided 80% study power to detect an odds ratio of 3.2 with a two-sided type I error rate of 5%. RESULTS: A total of 65 obese patients were monitored via simultaneous EUM and TOCO devices. The average gestational age was 39.0 weeks with 43 (66.15%) patients in latent labor. 35 (53.85%) patients were receiving oxytocin at the time of the recordings and 45 ajog.org
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